Form 4 for ACAD ACADIA PHARMACEUTICALS INC
Accepted 2023-05-19 00:00:00 ET · period of report 2023-05-17 · accession 0001209191-23-031241 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-05-19 | 2023-05-17 | ACAD | Teehan Brendan | EVP, COO, Head of Commercial | M - OptEx | — | +29.7K | 24.4K | New | — |
| D | 2023-05-19 | 2023-05-17 | ACAD | Teehan Brendan | EVP, COO, Head of Commercial | S - Sale+OE | $22.50 | -14.9K | 24.4K | -38% | -$334.6K |
| DM | 2023-05-19 | 2023-05-17 | ACAD | Teehan Brendan | EVP, COO, Head of Commercial | M - OptEx | $0.00 | -29.7K | 24.8K | -55% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-17 | M | A | 14,869 | — | 39,225 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. |
| 2 | Common | Common Stock | 2023-05-17 | M | A | 14,869 | — | 24,356 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. |
| 3 | Common | Common Stock | 2023-05-17 | S | D | 14,869 | $22.50 | 24,356 | D | — | — | |
| 4 | Derivative | Restricted Stock Units | 2023-05-17 | M | D | 14,869 | $0.00 | 24,782 | D | — · — to — | 14,869 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. (F4) The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period. |
| 5 | Derivative | Restricted Stock Units | 2023-05-17 | M | D | 14,869 | $0.00 | 24,782 | D | — · — to — | 14,869 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. (F3) The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. |